Shares in Bruker, Stratagene Bounce Back | GenomeWeb

Shares in Bruker BioSciences and Stratagene continued their bumpy ride, bouncing back this week to post gains of 8.42 percent and 6.74 percent, respectively. Both firms' stocks had led decliners in the BCW Index last week, following a week of big gains.

Molecular Devices posted the largest decline for the week — 2.96 percent — giving back its gain of 2.69 percent during last week's tracking period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.